載入...
Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma
Tivozanib is a novel vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGF TKI). Among other VEGF TKIs, tivozanib stands apart due to its selective kinase inhibitory properties as well as its high potency for inhibiting VEGF receptors 1 and 2. Tivozanib has been evaluated in se...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3693745/ https://ncbi.nlm.nih.gov/pubmed/23818763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S31442 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|